CHARACTERIZATION OF ANTIGEN-SPECIFIC CD4+ EFFECTOR T-CELLS INVIVO - IMMUNIZATION RESULTS IN A TRANSIENT POPULATION OF MEL-14-, CD45RB- HELPER-CELLS THAT SECRETES INTERLEUKIN-2 (IL-2), IL-3, IL-4, AND INTERFERON-GAMMA

被引:219
作者
BRADLEY, LM [1 ]
DUNCAN, DD [1 ]
TONKONOGY, S [1 ]
SWAIN, SL [1 ]
机构
[1] UNIV CALIF SAN DIEGO,THEODORE GILDRED CANC RES FACIL,LA JOLLA,CA 92093
关键词
D O I
10.1084/jem.174.3.547
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In previous studies we demonstrated that, following activation by mitogens or alloantigens, helper T cell precursors proliferate and differentiate in vitro to produce a population of effector cells that secrete high titers of lymphokines upon restimulation. In this report, we demonstrate that a similar effector population develops in vivo following primary antigen stimulation. When restimulated with specific antigen in vitro, CD4+ T cells from mice primed 5 to 7 days previously by subcutaneous administration of keyhole limpet hemocyanin (KLH) in adjuvant, produced high levels of interleukin 2 (IL-2), IL-4, and IL-3, and little or no interferon-gamma (IFN-gamma) or IL-5. The effector T cells provided excellent helper activity for in vitro antibody responses of 4-hydroxy-5-iodo-nitrophenyl acetic acid-primed B cells with the production principally of the immunoglobulin G1 (IgG1) and IgM isotypes, small quantities of IgG3, and no detectable IgG2a, or IgG2b. Antigen-specific secretion of IL-2, IL-3, and IL-4 by in vivo effectors was detectable by 12 hours following in vitro restimulation. IFN-gamma and IL-5 were not detected until 48 and 72 hours of culture, respectively, and low levels of these lymphokines were produced. Lymphokine production by primed CD4+ T cells could be induced as early as 3 days following immunization, peaked on day 5, and declined thereafter. The kinetics of in vivo appearance of effector CD4+ T cells that produce lymphokines upon restimulation in vitro were similar for each of the lymphokines examined. Mice depleted of precursor CD4+ T cells by adult thymectomy exhibited limited capacity to generate lymphokine secreting CD4+ T cells in response to primary immunization with KLH, suggesting that the majority of lymphokine producing T cells arise from short-lived and/or precursor cells. Separation of CD4+ T cells from KLH-primed mice on the basis of expression of the lymph node-specific homing receptor, MEL-14, revealed that antigen-specific production of IL-2, IL-3, IL-4, and IFN-gamma was exclusively associated with the MEL-14- subset of CD4+ T cells. Separation on the basis of CD45RB expression, demonstrated that antigen-specific lymphokine production was primarily associated with the minor CD45RB- population, which has been previously associated with memory activity. Our results indicate that primary in vivo immunization leads to the development of a transient population of helper-effectors with a unique phenotype that can produce large quantities of lymphokines and mediate excellent helper activity for B cells. This population may be of critical importance for in vivo regulation of the immune response.
引用
收藏
页码:547 / 559
页数:13
相关论文
共 32 条
  • [1] BENSASSON SZ, 1990, J IMMUNOL, V145, P1124
  • [2] BETZ M, 1990, J IMMUNOL, V145, P1046
  • [3] CHANGES IN CD45 ISOFORM EXPRESSION ACCOMPANY ANTIGEN-INDUCED MURINE T-CELL ACTIVATION
    BIRKELAND, ML
    JOHNSON, P
    TROWBRIDGE, IS
    PURE, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) : 6734 - 6738
  • [4] BROWNSTONE A, 1966, IMMUNOLOGY, V10, P465
  • [5] THE ROLE OF HELPER T-CELL PRODUCTS IN MOUSE B-CELL DIFFERENTIATION AND ISOTYPE REGULATION
    COFFMAN, RL
    SEYMOUR, BWP
    LEBMAN, DA
    HIRAKI, DD
    CHRISTIANSEN, JA
    SHRADER, B
    CHERWINSKI, HM
    SAVELKOUL, HFJ
    FINKELMAN, FD
    BOND, MW
    MOSMANN, TR
    [J]. IMMUNOLOGICAL REVIEWS, 1988, 102 : 5 - 28
  • [6] DEANS JP, 1989, J IMMUNOL, V143, P1233
  • [7] DIFFERENTIATION OF T-CELL LYMPHOKINE GENE-EXPRESSION - THE INVITRO ACQUISITION OF T-CELL MEMORY
    EHLERS, S
    SMITH, KA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (01) : 25 - 36
  • [8] FIRESTEIN GS, 1989, J IMMUNOL, V143, P518
  • [9] GAJEWSKI TF, 1989, J IMMUNOL, V143, P15
  • [10] LYMPHOCYTE HOMING RECEPTORS
    GALLATIN, M
    STJOHN, TP
    SIEGELMAN, M
    REICHERT, R
    BUTCHER, EC
    WEISSMAN, IL
    [J]. CELL, 1986, 44 (05) : 673 - 680